Outcome | Number of studies | Effect size and 95% interval | Test of null (2-Tail) | Heterogeneity | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Point estimate | Lower limit | Upper limit | Z-value | P-value | Q-value | df (Q) | P-value | I-squared | ||
SOD | 4 | 3.22 | 0.164 | 6.29 | 2.06 | 0.039 | 63.74 | 3 | < 0.001 | 95.29 |
GSH | 2 | 7.92 | − 13.12 | 28.96 | 0.73 | 0.461 | 39.10 | 1 | < 0.001 | 97.44 |
GPX | 3 | 4.83 | 0.10 | 9.56 | 2.004 | 0.045 | 29.09 | 2 | < 0.001 | 93.125 |
MDA | 4 | − 0.48 | − 3.81 | 2.83 | − 0.28 | 0.774 | 120.62 | 3 | < 0.001 | 97.51 |
Caspase3 | 6 | − 3.730 | − 7.84 | 0.38 | − 1.77 | 0.076 | 189.45 | 5 | < 0.001 | 97.36 |
Plasma glucose | 6 | − 4.54 | − 7.05 | − 1.85 | − 3.36 | 0.001 | 88.98 | 5 | < 0.001 | 94.38 |
Bcl-2 | 4 | 3.64 | − 0.70 | 8.00 | 1.64 | 0.101 | 108.68 | 3 | < 0.001 | 97.24 |
Bax | 3 | − 2.20 | − 9.19 | 4.78 | − 0.61 | 0.536 | 124.53 | 2 | < 0.001 | 98.39 |
Apoptosis index | 4 | − 8.61 | − 11.94 | − 5.28 | − 5.06 | < 0.001 | 21.58 | 3 | < 0.001 | 86.10 |
Total cholesterol | 4 | − 5.44 | − 8.19 | − 2.70 | − 3.88 | < 0.001 | 22.27 | 3 | < 0.001 | 86.53 |
Triglyceride (mg/dL) | 4 | − 6.60 | − 11.05 | − 2.15 | − 2.90 | 0.004 | 57.03 | 3 | < 0.001 | 94.74 |
HDL | 4 | 5.97 | 0.70 | 11.24 | 2.22 | 0.026 | 77.28 | 3 | < 0.001 | 96.11 |
VLDL | 4 | − 7.95 | − 13.62 | − 2.29 | − .275 | 0.006 | 57.36 | 3 | < 0.001 | 94.77 |
IL-6 | 3 | − 5.46 | − 14.02 | 3.09 | − 1.25 | 0.211 | 61.33 | 2 | < 0.001 | 96.73 |
TNF-a | 3 | − 11.57 | − 21.92 | − 1.22 | − 2.19 | 0.028 | 31.51 | 2 | < 0.001 | 93.65 |
IL-1β (ng/ml) | 2 | − 55.60 | − 156.32 | 45.12 | − 1.08 | 0.279 | 17.42 | 1 | < 0.001 | 94.26 |
p53 | 2 | − 10.32 | − 13.28 | − 7.37 | − 6.84 | < 0.001 | 1.57 | 1 | 0.210 | 36.36 |